Grouping: cTACE "bridging" treatment group (group A), DEB-TACE "bridging" treatment group (group B), patients with super-Milan standard HCC who did not receive any preoperative treatment during the same period were selected as the control group (group C). The A and B combination is referred to as the "bridging" treatment group. The "bridging" treatment group was divided into the successful downstaging group and the unsuccessful downstaging group. According to the pathological response of the tumor, the "bridging" treatment group was divided into the tumor necrosis rate ≥50.0% group and the tumor necrosis rate <50.0% group).
正在翻译中..